Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zhovtis Ryerson, Lana
61  Ergebnisse:
Personensuche X
?
1

Patient Preference for Subcutaneous Versus Intravenous Admi..:

Wiendl, Heinz ; Foley, John ; Defer, Gilles...
Neurology and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Critères d'évaluation exploratoires à l'IRM de l'étude NOVA..:

Arnold, Douglas ; Foley, John ; Defer, Gilles...
Revue Neurologique.  179 (2023)  - p. S145-S146 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Mu..:

Kister, Ilya ; Patskovsky, Yury ; Curtin, Ryan...
Annals of Neurology.  91 (2022)  6 - p. 782-795 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Stable multiple sclerosis patients on anti-CD20 therapy sho..:

Gratch, Daniel ; Zhovtis Ryerson, Lana
Multiple Sclerosis Journal.  28 (2022)  5 - p. 695-696 , 2022
Link: https://doi.org/10.1177/..
 
?
5

Natalizumab related progressive multifocal leukoencephalopa..:

Zhovtis Ryerson, Lana ; Major, Eugene O.
Drug Discovery Today: Disease Models.  32 (2020)  - p. 13-19 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Évaluation des valeurs de l'index des anticorps anti–JCV ch..:

Foley, John ; Zhovtis, Ryerson Lana ; Chang, Ih...
Revue Neurologique.  176 (2020)  - p. S125 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Natalizumab extended interval dosing (EID) is associated wi..:

Zhovtis, Ryerson Lana ; Foley, John ; Chang, Ih...
Revue Neurologique.  175 (2019)  - p. S102 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and tolerability of dimethyl fumarate in White-, A..:

Zhovtis Ryerson, Lana ; Green, Rivka ; Confident, Gladyne...
Therapeutic Advances in Neurological Disorders.  9 (2016)  6 - p. 454-461 , 2016
Link: https://doi.org/10.1177/..
 
?
9

No Difference in Disability Progression of MS Patients Trea..:

Fallon, Julia ; Kister, Ilya ; Zhovtis Ryerson, Lana
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
10

Safety and Efficacy of Extended Dose Natalizumab in Multipl..:

Zhovtis Ryerson, Lana ; Herbert, Joseph ; Kister, Ilya...
Neurology.  84 (2015)  14_supplement - p. , 2015
Link: https://doi.org/10.1212/..
 
?
11

Adult-onset spastic paraparesis: An approach to diagnostic ..:

Zhovtis Ryerson, Lana ; Herbert, Joseph ; Howard, Jonathan.
Journal of the Neurological Sciences.  346 (2014)  1-2 - p. 43-50 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Multicenter Retrospective Study Of Extended Dosing Of Natal..:

Herbert, Joseph ; Zhovtis Ryerson, Lana ; Tornatore, Carlo...
Neurology.  82 (2014)  10_supplement - p. , 2014
Link: https://doi.org/10.1212/..
 
?
13

Résultats de l'étude d'extension NOVA évaluant la préférenc..:

Wiendl, Heinz ; Foley, John ; Defer, Gilles...
Revue Neurologique.  180 (2024)  - p. S145 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Natalizumab Extended Interval Dosing (EID) is Associated wi..:

Ryerson, Lana Zhovtis ; Foley, John ; Kister, Ilya...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
15

Exploratory clinical efficacy and patient-reported outcomes..:

Ryerson, Lana Zhovtis ; Foley, John F ; Defer, Gilles...
Multiple Sclerosis and Related Disorders.  72 (2023)  - p. 104561 , 2023
Link: https://doi.org/10.1016/..
 
1-15